Stay updated on FLT3 Inhibitor Combo in AML Clinical Trial
Sign up to get notified when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.

Latest updates to the FLT3 Inhibitor Combo in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows Revision: v3.7.0 instead of v3.6.6, representing an update to the site’s interface/version for the study history page. The change does not modify the underlying study data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, indicating a new version of the page without altering substantive content.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now displays an updated platform release version, indicating Revision: v3.6.5 replacing the previous v3.6.4. This reflects a minor site maintenance update and does not alter the study record content.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now displays the latest release tag Revision: v3.6.4, replacing the previous Revision: v3.6.3.SummaryDifference0.0%

- Check70 days agoChange DetectedNew sections Study Status and Study Identification were added to the record history, and a new version entry (106) from 2026-06-23 was introduced along with an update on 2026-07-14; the 2025-09-12 entry was removed.SummaryDifference0.2%

- Check91 days agoChange DetectedThe revision history now includes a new entry for Revision: v3.6.3 and the previous Revision: v3.6.0 is removed from the history, representing a minor metadata update to the record viewer.SummaryDifference0.0%

Stay in the know with updates to FLT3 Inhibitor Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FLT3 Inhibitor Combo in AML Clinical Trial page.